Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney

Mayo Clinic Proceedings

Volumn 75, Issue 12, 2000, Pages 1236-1242

  Lau, Weber K O ^a   Blute, Michael L ^b   Weaver, Amy L ^c   Torres, Vicente E ^b   Zincke, Horst ^a  

^a Section of Biostatistics   (United States)

^b MAYO CLINIC   (United States)

^c Singapore General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PROTEINURIA;

EID: 0033673342     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.12.1236     Document Type: Article

References (31)

1. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Ural.1963:89:37-42.
2. Novick AC. Partial nephrectomy for renal cell carcinoma. Urology.1995:46:149-152.
3. Lerner SE, Hawkins CA, Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol.1996;155:1868-1873.
4. Van Poppel H, Bamelis B, Oyen R, Baert L. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol.1998;160(3, pt l):674-678.
5. Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology.1995;45:34-40.
6. Morgan WR, Zincke H. Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup. J Urol.1990:144:852-857.
7. Hafez KS, Novick AC, Campbell SC. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol.1997:157:2067-2070.
8. Cheng WS, Farrow GM, Zincke H. The incidence of multicentricity in renal cell carcinoma. J Urol.1991:146:1221-1223.
9. Kletscher BA, Qian J, Bostwick DC, Andrews PE, Zincke H. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol.1995;153(3, pt 2):904-906.
10. Bergstralh EJ, Kosanke JL, Jacobson SJ. Software for optimal matching in observational studies [letter]. Epidemiology.1996;7: 331-332.
11. Zincke H, Sen SE. Experience with extracorporeal surgery and autotransplantation for renal cell and transitional cell cancer of the kidney. J Urol.1988;140:25-27.
12. Wilson DM, Andersen RL. Protein-osmolality ratio for the quantitative assessment of proteinuria from a random urinalysis sample. Am J Clin Pathol.1993;100:419-424.
13. Novick AC. Nephron-sparing surgery for RCC in patients with a normal opposite kidney. Contemp Urol.1999:11:28-29.
14. Van Poppel H, Baert L. Elective conservative surgery for renal cell carcinoma. Am UrolAssoc Update Series.1994:31:246-251.
15. Dechet CB, Sebo T, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J U ml.1999; 162:1282-1284.
16. Licht MR, Novick AC, Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol.1994; 152: 39-42.
17. D'Armiento M, Damiano R, Feleppa B, Perdona S, Oriani G, De Sio M. Elective conservative surgery for renal carcinoma versus radical nephrectomy: a prospective study. Br J Urol.1997;79:1519.
18. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. I999;281:1628-1631.
19. Zincke H, Engen DE, Henning KM, McDonald MW. Treatment of renal cell carcinoma by in situ partial nephrectomy and extracorporeal operation with autotransplantation. Mayo Clin Proc.1985;60: 651-662.
20. Montie JE. The incidental renal mass: management alternatives. Urol Clin North Am.1991;18:427-436.
21. Déchet CB, Blute ML, Zincke H. Nephron-preserving surgery for unilateral renal cell carcinoma: which pathologic variables contribute to contralateral renal tumor recurrence? [abstract]. J Urol.1998; 159(suppl):169.
22. Frank I, Blute ML, Weaver A, Spotts B, Zincke H. Stage- and grade-specific long-term outcome prediction after radical nephrectomy for unilateral renal cell carcinoma [abstract]. J Urol.2000; 163(suppl):175.
23. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR. Longterm follow-up after partial removal of a solitary kidney. N Engl J Med.1991 ;325:1058-1062.
24. Remuzzi A, Mazeska M, Gephardt GN, Novick AC, Brenner BM, Remuzzi G. Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int.1995;48:155162.
25. Anderson CF, Velosa JA, Frohnert PP, et al. The risks of unilateral nephrectomy: status of kidney donors 10 to 20 years postoperatively. Mayo Clin Proc.1985;60:367-374.
26. Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet.1992;340:807-810.
27. Eberhard OK, Kliem V, Offner G, et al. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Clin Transplant.1997; 11(5, pt 1):415-419.
28. Shapiro JA, Williams, MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol.1999; 149:521-530.
29. Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia.1999;42:107-112.
30. Shapiro JA, Williams MA, Weiss NA. Body mass index and risk of renal cell carcinoma. Epidemiology.1999; 10:188-191.
31. Yuan JM, Castelao JE, Gago-Dominguez M, Yu MC, Ross RK. Tobacco use in relation to renal cell carcinoma. Cancer Epidemiol Biomarkers Prev.1998;7:429-433.